Perrigo Company PLC
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nut… Read more
Perrigo Company PLC (PRGO) - Net Assets
Latest net assets as of September 2025: $4.45 Billion USD
Based on the latest financial reports, Perrigo Company PLC (PRGO) has net assets worth $4.45 Billion USD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($10.08 Billion) and total liabilities ($5.64 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $4.45 Billion |
| % of Total Assets | 44.09% |
| Annual Growth Rate | 10.04% |
| 5-Year Change | -23.62% |
| 10-Year Change | -56.96% |
| Growth Volatility | 48.11 |
Perrigo Company PLC - Net Assets Trend (1991–2024)
This chart illustrates how Perrigo Company PLC's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Perrigo Company PLC (1991–2024)
The table below shows the annual net assets of Perrigo Company PLC from 1991 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $4.32 Billion | -9.41% |
| 2023-12-31 | $4.77 Billion | -1.53% |
| 2022-12-31 | $4.84 Billion | -6.01% |
| 2021-12-31 | $5.15 Billion | -8.90% |
| 2020-12-31 | $5.66 Billion | -2.57% |
| 2019-12-31 | $5.80 Billion | +2.40% |
| 2018-12-31 | $5.67 Billion | -8.14% |
| 2017-12-31 | $6.17 Billion | +3.58% |
| 2016-12-31 | $5.96 Billion | -40.64% |
| 2015-12-31 | $10.04 Billion | +15.44% |
| 2014-12-31 | $8.69 Billion | +0.01% |
| 2013-12-31 | $8.69 Billion | +272.67% |
| 2012-12-31 | $2.33 Billion | +25.91% |
| 2011-12-31 | $1.85 Billion | +21.01% |
| 2010-12-31 | $1.53 Billion | +40.63% |
| 2009-12-31 | $1.09 Billion | +18.09% |
| 2008-12-31 | $921.92 Million | -1.26% |
| 2007-12-31 | $933.72 Million | +23.76% |
| 2006-12-31 | $754.47 Million | +17.75% |
| 2005-12-31 | $640.74 Million | +8.45% |
| 2004-12-31 | $590.84 Million | +10.18% |
| 2003-12-31 | $536.23 Million | +19.58% |
| 2002-12-31 | $448.42 Million | +7.76% |
| 2001-12-31 | $416.14 Million | +7.84% |
| 2000-12-31 | $385.88 Million | +6.08% |
| 1999-12-31 | $363.75 Million | +2.52% |
| 1998-12-31 | $354.80 Million | +2.69% |
| 1997-12-31 | $345.50 Million | -18.53% |
| 1996-12-31 | $424.10 Million | +11.25% |
| 1995-12-31 | $381.20 Million | +11.92% |
| 1994-12-31 | $340.60 Million | +5.38% |
| 1993-12-31 | $323.20 Million | +37.53% |
| 1992-12-31 | $235.00 Million | +27.93% |
| 1991-12-31 | $183.70 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Perrigo Company PLC's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 225210000000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $6.73 Billion | 155.90% |
| Other Comprehensive Income | $-162.40 Million | -3.76% |
| Total Equity | $4.32 Billion | 100.00% |
Perrigo Company PLC Competitors by Market Cap
The table below lists competitors of Perrigo Company PLC ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Qfin Holdings, Inc.
F:CKR0
|
$1.36 Billion |
|
Nippon Kayaku Co. Ltd
F:NP7
|
$1.36 Billion |
|
Despegar.com Corp
NYSE:DESP
|
$1.36 Billion |
|
Nuode Investment Co Ltd
SHG:600110
|
$1.36 Billion |
|
Jenoptik AG
F:JEN
|
$1.36 Billion |
|
JinkoSolar Holding Company Limited
NYSE:JKS
|
$1.36 Billion |
|
Sonos Inc
NASDAQ:SONO
|
$1.36 Billion |
|
Fujian Funeng Co Ltd
SHG:600483
|
$1.36 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Perrigo Company PLC's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,767,900,000 to 4,319,400,000, a change of -448,500,000 (-9.4%).
- Net loss of 171,800,000 reduced equity.
- Dividend payments of 152,500,000 reduced retained earnings.
- Other comprehensive income decreased equity by 173,100,000.
- Other factors increased equity by 48,900,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-171.80 Million | -3.98% |
| Dividends Paid | $152.50 Million | -3.53% |
| Other Comprehensive Income | $-173.10 Million | -4.01% |
| Other Changes | $48.90 Million | +1.13% |
| Total Change | $- | -9.41% |
Book Value vs Market Value Analysis
This analysis compares Perrigo Company PLC's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.32x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 3.77x to 0.32x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1991-12-31 | $2.63 | $9.94 | x |
| 1992-12-31 | $3.06 | $9.94 | x |
| 1993-12-31 | $4.19 | $9.94 | x |
| 1994-12-31 | $4.45 | $9.94 | x |
| 1995-12-31 | $4.90 | $9.94 | x |
| 1996-12-31 | $5.48 | $9.94 | x |
| 1997-12-31 | $4.61 | $9.94 | x |
| 1998-12-31 | $4.72 | $9.94 | x |
| 1999-12-31 | $4.93 | $9.94 | x |
| 2000-12-31 | $5.21 | $9.94 | x |
| 2001-12-31 | $5.58 | $9.94 | x |
| 2002-12-31 | $6.30 | $9.94 | x |
| 2003-12-31 | $7.42 | $9.94 | x |
| 2004-12-31 | $7.64 | $9.94 | x |
| 2005-12-31 | $6.81 | $9.94 | x |
| 2006-12-31 | $8.04 | $9.94 | x |
| 2007-12-31 | $9.81 | $9.94 | x |
| 2008-12-31 | $9.85 | $9.94 | x |
| 2009-12-31 | $11.71 | $9.94 | x |
| 2010-12-31 | $16.35 | $9.94 | x |
| 2011-12-31 | $19.67 | $9.94 | x |
| 2012-12-31 | $24.67 | $9.94 | x |
| 2013-12-31 | $75.20 | $9.94 | x |
| 2014-12-31 | $75.20 | $9.94 | x |
| 2015-12-31 | $71.79 | $9.94 | x |
| 2016-12-31 | $41.58 | $9.94 | x |
| 2017-12-31 | $43.27 | $9.94 | x |
| 2018-12-31 | $40.98 | $9.94 | x |
| 2019-12-31 | $42.52 | $9.94 | x |
| 2020-12-31 | $41.55 | $9.94 | x |
| 2021-12-31 | $38.56 | $9.94 | x |
| 2022-12-31 | $36.00 | $9.94 | x |
| 2023-12-31 | $35.24 | $9.94 | x |
| 2024-12-31 | $31.44 | $9.94 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Perrigo Company PLC utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -3.98%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -3.93%
- • Asset Turnover: 0.45x
- • Equity Multiplier: 2.23x
- Recent ROE (-3.98%) is below the historical average (3.86%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1991 | 15.57% | 6.98% | 1.29x | 1.73x | $10.23 Million |
| 1992 | 18.98% | 7.81% | 1.38x | 1.76x | $21.10 Million |
| 1993 | 16.96% | 8.19% | 1.32x | 1.57x | $22.48 Million |
| 1994 | 13.04% | 6.19% | 1.29x | 1.63x | $10.34 Million |
| 1995 | 10.44% | 5.12% | 1.42x | 1.44x | $1.68 Million |
| 1996 | 10.61% | 5.33% | 1.32x | 1.51x | $2.60 Million |
| 1997 | -14.95% | -5.72% | 1.51x | 1.73x | $-86.11 Million |
| 1998 | 0.42% | 0.17% | 1.51x | 1.64x | $-33.91 Million |
| 1999 | 5.32% | 2.61% | 1.42x | 1.44x | $-16.98 Million |
| 2000 | 7.17% | 3.67% | 1.31x | 1.49x | $-10.93 Million |
| 2001 | 12.06% | 6.07% | 1.39x | 1.43x | $8.58 Million |
| 2002 | 12.05% | 6.54% | 1.28x | 1.44x | $9.21 Million |
| 2003 | 15.02% | 8.97% | 1.18x | 1.42x | $26.94 Million |
| 2004 | -59.74% | -34.47% | 0.60x | 2.89x | $-412.07 Million |
| 2005 | 11.14% | 5.22% | 0.78x | 2.73x | $7.33 Million |
| 2006 | 9.78% | 5.10% | 0.75x | 2.55x | $-1.65 Million |
| 2007 | 14.54% | 7.45% | 0.71x | 2.76x | $42.40 Million |
| 2008 | 15.62% | 7.18% | 0.79x | 2.75x | $51.86 Million |
| 2009 | 20.48% | 9.81% | 0.73x | 2.85x | $113.87 Million |
| 2010 | 22.18% | 12.31% | 0.86x | 2.09x | $186.29 Million |
| 2011 | 21.70% | 12.66% | 0.79x | 2.17x | $216.51 Million |
| 2012 | 18.95% | 12.48% | 0.66x | 2.30x | $208.76 Million |
| 2013 | 2.36% | 5.06% | 0.29x | 1.59x | $-663.99 Million |
| 2014 | 2.36% | 5.06% | 0.29x | 1.60x | $-663.99 Million |
| 2015 | 1.27% | 2.78% | 0.24x | 1.93x | $-875.77 Million |
| 2016 | -67.35% | -75.99% | 0.38x | 2.33x | $-4.61 Billion |
| 2017 | 1.94% | 2.42% | 0.43x | 1.88x | $-497.45 Million |
| 2018 | 2.31% | 2.77% | 0.43x | 1.94x | $-435.80 Million |
| 2019 | 2.52% | 3.78% | 0.34x | 1.95x | $-434.28 Million |
| 2020 | -2.88% | -3.98% | 0.36x | 2.03x | $-728.11 Million |
| 2021 | -1.34% | -1.66% | 0.40x | 2.02x | $-584.07 Million |
| 2022 | -2.90% | -3.16% | 0.40x | 2.28x | $-624.81 Million |
| 2023 | -0.27% | -0.27% | 0.43x | 2.27x | $-489.49 Million |
| 2024 | -3.98% | -3.93% | 0.45x | 2.23x | $-603.74 Million |
Industry Comparison
This section compares Perrigo Company PLC's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $439,452,927
- Average return on equity (ROE) among peers: -31.68%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Perrigo Company PLC (PRGO) | $4.45 Billion | 15.57% | 1.27x | $1.36 Billion |
| Ascend Wellness Holdings Inc (AAWH) | $71.80 Million | -118.37% | 11.54x | $48.90 Million |
| AB Science S.A (ABSCF) | $-21.01 Million | 0.00% | 0.00x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $-294.68K | 0.00% | 0.00x | $603.58K |
| Aurora Cannabis Inc (ACB) | $521.74 Million | -156.52% | 0.78x | $195.20 Million |
| Acreage Holdings Inc (ACRDF) | $494.79 Million | -30.37% | 0.40x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $29.91 Million | 0.00% | 0.07x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.72 Million | -18.78% | 0.11x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $20.08 Million | -10.91% | 0.33x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $21.19 Million | 12.93% | 1.96x | $1.85 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.25 Billion | 5.19% | 0.72x | $85.61 Million |